Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway
Authors
Keywords
Intrahepatic cholangiocarcinoma (IHCC), CXC chemokine ligand-12 (CXCL12)/chemokine receptor type 4 (CXCR4), Prognosis, Metastasis, Wnt pathway
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 33, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-12-04
DOI
10.1186/s13046-014-0103-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
- (2014) Zhigang Zhang et al. BMC CANCER
- SDF-1/CXCR4 promotes epithelial–mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway
- (2014) Ting-hua Hu et al. CANCER LETTERS
- A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer
- (2014) M. D. Galsky et al. CLINICAL CANCER RESEARCH
- Differential regulation of orphan nuclear receptor TR3 transcript variants by novel vascular growth factor signaling pathways
- (2014) Shengqiang Zhao et al. FASEB JOURNAL
- Silencing of CXCR4 Inhibits Tumor Cell Proliferation and Neural Invasion in Human Hilar Cholangiocarcinoma
- (2014) Xin-Yu Tan et al. Gut and Liver
- Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention
- (2014) Samantha Kaufhold et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways
- (2014) Tammy Sobolik et al. MOLECULAR BIOLOGY OF THE CELL
- The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis
- (2014) Cheng-Fei Liu et al. PLoS One
- Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines
- (2013) Masanobu Tsubaki et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway
- (2013) T Yu et al. ONCOGENE
- Combined Wnt/β-Catenin, Met, and CXCL12/CXCR4 Signals Characterize Basal Breast Cancer and Predict Disease Outcome
- (2013) Jane D. Holland et al. Cell Reports
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
- (2012) Shan-shan Zhang et al. BMC Medicine
- SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
- (2012) Xuqi Li et al. CANCER LETTERS
- A review on CXCR4/CXCL12 axis in oncology: No place to hide
- (2012) Urszula M. Domanska et al. EUROPEAN JOURNAL OF CANCER
- The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer
- (2012) Marcello Ferretti Fanelli et al. HISTOPATHOLOGY
- Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3
- (2012) Liang Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of the stromal-derived factor-1 (SDF-1)–CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma
- (2012) Alessandra Gentilini et al. JOURNAL OF HEPATOLOGY
- Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type
- (2012) Michiyo Higashi et al. PATHOBIOLOGY
- Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells
- (2011) Masato Tamura et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Silencing of CXCR4 Blocks Progression of Ovarian Cancer and Depresses Canonical Wnt Signaling Pathway
- (2011) Jia Wang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting
- (2011) Marina Y. Konopleva et al. JOURNAL OF CLINICAL ONCOLOGY
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis
- (2010) Man Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of CXCR4/SDF-1α in the migratory phenotype of hepatoma cells that have undergone epithelial–mesenchymal transition in response to the transforming growth factor-β
- (2009) Esther Bertran et al. CELLULAR SIGNALLING
- Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth
- (2009) Stacy Porvasnik et al. PROSTATE
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- (2008) B. Nervi et al. BLOOD
- Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway
- (2008) Z Wang et al. BRITISH JOURNAL OF CANCER
- Wnt1 overexpression promotes tumour progression in non-small cell lung cancer
- (2008) Cheng-Long Huang et al. EUROPEAN JOURNAL OF CANCER
- CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
- (2008) J A Burger et al. LEUKEMIA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started